Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS)
- PMID: 35355927
- PMCID: PMC8958273
- DOI: 10.1016/j.ijcha.2022.101012
Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS)
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) or coronavirus disease 2019 (COVID-19) initially surfaced in December 2019 from Wuhan, China, sweeping the world with various strains, forcing the WHO to declare a pandemic epidemic in March 2020. Furthermore, COVID-19 manifests with a wide array of presentations from fever and fatigue to severe respiratory and cardiovascular complications. Post-COVID-19 syndrome is poorly understood affecting COVID-19 survivors at all levels of disease severity. The disease is most associated with post-discharge dyspnea and fatigue. However, other persistent symptoms as chest pains, palpitations, smell, and taste dysfunctions. Patients with high concentrations of CRP and creatinine in the acute phase of Covid-19 are more prone to cardiac sequelae. Therefore, high levels of cardiac-sensitive troponin and hypokalaemia can also be used for risk stratification. Furthermore, Cardiac damage can manifest as myocarditis, pericarditis, rhythm abnormalities. The use of different diagnostic modalities like electrocardiogram (ECG), echocardiogram, and cardiac magnetic resonance imaging (MRI)(CMR) to evaluate the myocardial damage were studied. However, Cardiovascular complications are a common manifestation of PASC, classification of severity of cardiac symptoms and the emergence of CMR as a diagnostic tool needs more evidence.
Keywords: ACE2, Angiotensin-converting enzyme 2; CAMKII, calmodulin-dependent protein kinase II; CMR, Cardiac magnetic resonance imaging; COVID-19; COVID-19, Coronavirus disease 2019; CVD, Cardiovascular disease; Cardiovascular diseases; DAMPs, damage-associated molecular patterns; IL, interleukin; Myocardial infarction; NOAC, novel oral anticoagulation; PACS, Post-Acute COVID-19 syndrome; Post covid sequelae; RAAS, Renin-Angiotensin Aldosterone System dysregulation; SARS-CoV 2, severe acute respiratory syndrome coronavirus 2; TMPRS2, transmembrane protease serine 2; TNF-Alpha, Tumor necrosis factor-alpha; TTE, transthoracic echocardiogram; UFH, Unfractionated heparin; VTE, venous thromboembolism; WHO, World health organization.
© 2022 Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?Am Heart J Plus. 2021 May;5:100025. doi: 10.1016/j.ahjo.2021.100025. Epub 2021 Jun 24. Am Heart J Plus. 2021. PMID: 34192289 Free PMC article. Review.
-
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28. Expert Rev Anti Infect Ther. 2021. PMID: 32921216 Review.
-
Long-term Cardiovascular Manifestations and Complications of COVID-19: Spectrum and Approach to Diagnosis and Management.R I Med J (2013). 2022 Sep 1;105(7):16-22. R I Med J (2013). 2022. PMID: 35930485 Review.
-
Coronavirus disease 2019 and cardiovascular system: A narrative review.Int J Cardiol Heart Vasc. 2020 Jun 3;29:100557. doi: 10.1016/j.ijcha.2020.100557. eCollection 2020 Aug. Int J Cardiol Heart Vasc. 2020. PMID: 32550259 Free PMC article. Review.
-
The negative effects of long COVID-19 on cardiovascular health and implications for the presurgical examination.J Osteopath Med. 2024 Oct 17;125(3):105-117. doi: 10.1515/jom-2024-0109. eCollection 2025 Mar 1. J Osteopath Med. 2024. PMID: 39417730 Review.
Cited by
-
Abnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection.Int J Cardiol Heart Vasc. 2022 Dec;43:101144. doi: 10.1016/j.ijcha.2022.101144. Epub 2022 Oct 28. Int J Cardiol Heart Vasc. 2022. PMID: 36321063 Free PMC article.
-
Recent highlights on specific aspects of oral anticoagulation in difficult clinical scenarios from the International Journal of Cardiology Heart & Vasculature.Int J Cardiol Heart Vasc. 2023 Aug 23;48:101260. doi: 10.1016/j.ijcha.2023.101260. eCollection 2023 Oct. Int J Cardiol Heart Vasc. 2023. PMID: 37663615 Free PMC article. No abstract available.
-
Unveiling the Clinical Spectrum of Post-COVID-19 Conditions: Assessment and Recommended Strategies.Cureus. 2024 Jan 23;16(1):e52827. doi: 10.7759/cureus.52827. eCollection 2024 Jan. Cureus. 2024. PMID: 38406111 Free PMC article. Review.
-
Myocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the Literature.Cureus. 2023 Jul 25;15(7):e42444. doi: 10.7759/cureus.42444. eCollection 2023 Jul. Cureus. 2023. PMID: 37637608 Free PMC article. Review.
-
Potential Beneficial Effects of Naringin and Naringenin on Long COVID-A Review of the Literature.Microorganisms. 2024 Feb 4;12(2):332. doi: 10.3390/microorganisms12020332. Microorganisms. 2024. PMID: 38399736 Free PMC article. Review.
References
-
- Shi S., Qin M.u., Shen B.o., Cai Y., Liu T., Yang F., Gong W., Liu X.u., Liang J., Zhao Q., Huang H.e., Yang B.o., Huang C. Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan. China. JAMA Cardiol. 2020;5(7):802. doi: 10.1001/jamacardio.2020.0950. - DOI - PMC - PubMed
-
- Shah, W.; Hillman, T.; Playford, E.D.; Hishmeh, L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ2021,372, n136. - PubMed
-
- Wang D., Hu B.o., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China. JAMA. 2020;323(11):1061. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous